{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:05:12Z","timestamp":1790636712544,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H02215"],"award-info":[{"award-number":["17H02215"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15H05935"],"award-info":[{"award-number":["15H05935"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15K21745"],"award-info":[{"award-number":["15K21745"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17H06047"],"award-info":[{"award-number":["17H06047"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18H04966"],"award-info":[{"award-number":["18H04966"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JPMJCR1655"],"award-info":[{"award-number":["JPMJCR1655"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.neuropharm.2018.10.022","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T16:27:34Z","timestamp":1539620854000},"page":"122-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-6377","authenticated-orcid":false,"given":"Mustafa","family":"Korkutata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-6292","authenticated-orcid":false,"given":"Tsuyoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-8193","authenticated-orcid":false,"given":"Yoan","family":"Cherasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Ioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Duo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Murakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-4474","authenticated-orcid":false,"given":"Michael","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.10.022_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002826-200009000-00008","article-title":"Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report","volume":"23","author":"Aragona","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib2","unstructured":"Cai, X., Qian, C., Gould, S., Zhai, H., 2008. Multi-functional Small Molecules as Anti-proliferative Agents. US Patent 20080221132A1."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00778","article-title":"LASSBio-897 reduces lung injury induced by silica particles in mice: potential interaction with the A2A receptor","volume":"8","author":"Carvalho","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib4","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice","volume":"19","author":"Chen","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/365855a0","article-title":"Phosphorylated CREB binds specifically to the nuclear protein CBP","volume":"365","author":"Chrivia","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib6","series-title":"Sleep Disorders and Sleep Deprivation: an Unmet Public Health Problem. 3, Extent and Health Consequences of Chronic Sleep Loss and Sleep Disorders","author":"Colten","year":"2006"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib7","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1021\/jm100541c","article-title":"Discovery of the dual orexin receptor antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia","volume":"53","author":"Cox","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib8","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1021\/jm4011669","article-title":"Adenosine A2A receptor as a drug discovery target","volume":"57","author":"de Lera Ruiz","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib9","article-title":"Insomnia disorder in adolescence: diagnosis, impact, and treatment","author":"de Zambotti","year":"2017","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(00)00399-X","article-title":"SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional \u201catypical\u201d adenosine A(2A) receptor","volume":"401","author":"El Yacoubi","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/187152709788921672","article-title":"Sleep-inducing factors","volume":"8","author":"Garc\u00eda-Garc\u00eda","year":"2009","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11302-008-9105-3","article-title":"Allosteric modulation of adenosine receptors","volume":"5","author":"G\u00f6bly\u00f6s","year":"2009","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2869.2004.00418.x","article-title":"Sleep quantity, sleep difficulties and their perceived consequences in a representative sample of some 2000 British adults","volume":"13","author":"Groeger","year":"2004","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib15","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.str.2013.09.020","article-title":"The role of a sodium ion binding site in the allosteric modulation of the A2A adenosine G protein-coupled receptor","volume":"21","author":"Guti\u00e9rrez-de-Ter\u00e1n","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib16","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1523\/JNEUROSCI.4501-04.2005","article-title":"Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons","volume":"25","author":"Huitron-Resendiz","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib17","first-page":"47","article-title":"CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity","volume":"251","author":"Hutchison","year":"1989","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/17512433.2014.966813","article-title":"Suvorexant for the treatment of insomnia","volume":"7","author":"Jacobson","year":"2014","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1046\/j.1460-9568.2003.02532.x","article-title":"Local energy depletion in the basal forebrain increases sleep","volume":"17","author":"Kalinchuk","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib20","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/sj.bjp.0702202","article-title":"Characterization of adenosine receptors evoking excitation of mesenteric afferents in the rat","volume":"125","author":"Kirkup","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","article-title":"Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics","volume":"31","author":"Kitamura","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib22","first-page":"R994","article-title":"Sleep-promoting effects of endogenous pyrogen (interleukin-1)","volume":"246","author":"Krueger","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib23","doi-asserted-by":"crossref","first-page":"R1715","DOI":"10.1152\/ajpregu.00247.2005","article-title":"Effects on sleep of microdialysis of adenosine A1 and A2a receptor analogs into the lateral preoptic area of rats","volume":"289","author":"Methippara","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0166-2236(90)90045-C","article-title":"Regulation of cAMP-inducible genes by CREB","volume":"13","author":"Montminy","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","article-title":"Plat-E: an efficient and stable system for transient packaging of retroviruses","volume":"7","author":"Morita","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jsr.12434","article-title":"Oral administration of Japanese sake yeast (Saccharomyces cerevisiae sake) promotes non-rapid eye movement sleep in mice via adenosine A2A receptors","volume":"25","author":"Nakamura","year":"2016","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002107","article-title":"Anti-inflammatory preconditioning by agonists of adenosine A1 receptor","volume":"3","author":"Nakav","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib28","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(96)00250-6","article-title":"Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats","volume":"307","author":"Nekooeian","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib31","doi-asserted-by":"crossref","DOI":"10.3791\/53678","article-title":"Polygraphic Recording Procedure for Measuring Sleep in Mice","author":"Oishi","year":"2016","journal-title":"JoVE"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1440-1819.2002.01012.x","article-title":"Prevalence of insomnia in various psychiatric diagnostic categories","volume":"56","author":"Okuji","year":"2002","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib33","first-page":"14","article-title":"Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs","volume":"268","author":"Pardridge","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib34","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.276.5316.1265","article-title":"Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness","volume":"276","author":"Porkka-Heiskanen","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib36","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1073\/pnas.0608581103","article-title":"Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep","volume":"103","author":"Qu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib37","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5664\/jcsm.26929","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0972-2327.64628","article-title":"Diagnosis and treatment of chronic insomnia","volume":"13","author":"Saddichha","year":"2010","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib39","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1460-9568.1999.00569.x","article-title":"Region-dependent difference in the sleep-promoting potency of an adenosine A2A receptor agonist","volume":"11","author":"Satoh","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0306-4522(01)00383-9","article-title":"An adenosine A2A agonist increases sleep and induces Fos in ventrolateral preoptic neurons","volume":"107","author":"Scammell","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2017.09.015","article-title":"Identifying the best sleep measure to screen clinical insomnia in a psychiatric population","volume":"41","author":"Seow","year":"2018","journal-title":"Sleep Med."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib42","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1073\/pnas.1621423114","article-title":"Crystal structure of the adenosine A2A receptor bound to an antagonist reveals a potential allosteric pocket","volume":"114","author":"Sun","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/sleep\/24.6.665","article-title":"Insomnia and health problems in Canadians","volume":"24","author":"Sutton","year":"2001","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1602\/neurorx.2.1.54","article-title":"Small molecular drug transfer across the blood-brain barrier via Carrier-mediated transport systems","volume":"2","author":"Tsuji","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib45","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1212\/01.WNL.0000095222.41066.5E","article-title":"Sleep regulation in adenosine A2A receptor-deficient mice","volume":"61","author":"Urade","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000139363","article-title":"Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics","volume":"51","author":"Vgontzas","year":"1995","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2018.10.022_bib47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrd2464","article-title":"Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time","volume":"7","author":"Wafford","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-pharmtox-010611-134525","article-title":"Drugs for allosteric sites on receptors","volume":"54","author":"Wenthur","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.10.022_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pbb.2013.11.029","article-title":"A mouse model mimicking human first night effect for the evaluation of hypnotics","volume":"116","author":"Xu","year":"2014","journal-title":"Pharmacol. Biochem. Behav."}],"updated-by":[{"DOI":"10.1016\/j.neuropharm.2019.04.027","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000}}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818308074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818308074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T01:31:58Z","timestamp":1655343118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818308074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":49,"alternative-id":["S0028390818308074"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.10.022","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.neuropharm.2019.04.027","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}